Rituximab
RG1124587
Phase 2 mab active
Quick answer
Rituximab for Chronic Lymphocytic Leukemia is a Phase 2 program (mab) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Chronic Lymphocytic Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- active